B cell depletion can be effective in multiple sclerosis but failed in a patient with advanced childhood cerebral X-linked adrenoleukodystrophy

Rituximab exerts its clinical efficacy by its specific pattern of depletion of CD20(+) B lymphocytes and it has been demonstrated that rituximab is an effective treatment for relapsing remitting multiple sclerosis. X-linked adrenoleukodystrophy (X-ALD), the most common monogenetic neuroinflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosewich, Hendrik, Nessler, Stefan, Brück, Wolfgang, Gärtner, Jutta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696829/
https://www.ncbi.nlm.nih.gov/pubmed/31452685
http://dx.doi.org/10.1177/1756286419868133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696829/
https://www.ncbi.nlm.nih.gov/pubmed/31452685
http://dx.doi.org/10.1177/1756286419868133

Ejemplares similares